Search clinical trials for: PegIFN lambda

Total 401 results

Merck Sharp & Dohme LLC

Withdrawn

A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113)

Hepatitis C
Daniel Maroti
Wayne State University

Active, not recruiting

Does the First Interview Matter: A Comparing Life Stress Interview Versus a Standard Psychiatric Intake Interview for Patients With Functional Somatic Disorder

Somatic Symptom Disorder | Functional Somatic Disorder

Sweden
Alexandria University

Active, not recruiting

Effectiveness of Two Skeletally Anchored Force Mechanics for Skeletal Class II Correction in Growing Patients

Malocclusion

Egypt
Beni-Suef University

Completed

Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 (HCV)

Hepatitis C Virus Infection
St. Olavs Hospital
Odense University Hospital; Oslo University Hospital; University Hospital of... and other collaborators

Recruiting

Long-acting Low Dose Ropeginterferon for Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis (BosuPeg)

Chronic Myeloid Leukemia

Norway, Denmark, Finland, Sweden
Nantong University

Unknown

Digital Navigation Enhances Cervical Pedicle Screw Placement Accuracy and Safety

Cervical Spine Fracture
Riphah International University

Completed

Effects of Scapular Stabilization Program in Patients Chronic Non-specific Neck Pain

Neck Pain

Pakistan
University of Catanzaro

Unknown

CFD Analysis and Risk of TOS in Sport (COFLUTOSPO)

Sport Injury | Thoracic Outlet Syndrome

Italy
ANRS, Emerging Infectious Diseases
Janssen-Cilag Ltd.

Completed

Telaprevir in HIV-HCV Coinfected Patients Who Had Previously Failed a Peginterferon-Ribavirin Regimen (TelapreVIH)

HIV Infection | Hepatitis C, Chronic

France
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
The First Affiliated Hospital with Nanjing Medical...

Recruiting

Omission of ALND in Breast Cancer Patients With Axillary pCR

Breast Cancer | Pathological Complete Response | Axillary Lymph Node Dissection | Neoadjuvant Systemic Therapy | Axillary Lymph

China
University of Zurich
Balgrist University Hospital; Wings for Life; ETH Zurich

Recruiting

Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait (DBS-SCI)

Spinal Cord Injury

Switzerland
Medical University of Warsaw

Completed

Flash Glucose Monitoring in Gestational Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial (FLAMINGO)

Gestational Diabetes Mellitus

Poland
Merck Sharp & Dohme LLC

Completed

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Melanoma | Renal Cell Carcinoma
Incyte Corporation

Recruiting

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

Moderate to Severe Asthma

Korea, Republic of, United States, Spain, Poland, Japan, Canada, Germany, Belgium, Argentina
Koneksa Health

Completed

Study Comparing At-Home Mobile Spirometry to In-Clinic in Moderate Asthma Participants Taking Long-Acting Beta Agonist (LEARN)

Moderate Asthma

United States
Bristol-Myers Squibb

Withdrawn

Safety and Efficacy Study of Pegylated Interferon Lambda Versus Pegylated Interferon Alfa, Plus Ribavirin in Subjects With Hepatitis C

Hepatitis C Virus (HCV)

India, Korea, Republic of, Poland, Taiwan, Spain, Canada, Russian Federation, Colombia, Singapore, Netherlands, Ireland, United Kingdom, Czech Republic, Hungary, Romania, Hong Kong, Turkey, United States, China, Egypt
University of Liege
Institut Straumann AG

Active, not recruiting

Clinical and Dimensional Outcomes of Sealing Socket Abutment Combined to Alveolar Ridge Preservation

Non-maintainable Posterior Tooth (Molars and Premolars)

Belgium
Bristol-Myers Squibb

Completed

Efficacy and Safety Evaluation of a Regimen Consisting of Peginterferon Lambda-1a + Ribavirin + Daclatasvir (Lambda + RBV + DCV) in HCV Genotype 1b Treatment naïve Patients or Prior Relapsers to Peginterferon Alfa + Ribavirin (Alfa + RBV) Therapy (STRUCTURE)

Hepatitis C

France, Germany, Italy, Japan, Korea, Republic of, Russian Federation, Taiwan, United Kingdom, United States, Spain, Israel, Argentina, Poland
Washington University School of Medicine

Completed

Haiti Rural School Feeding Study: Effect of Vita Mamba on Anemia and Hemoglobin Concentrations

Malnutrition
Centre for Infectious Disease Research in Zambia
London School of Hygiene and Tropical Medicine; Unilever R&D

Completed

Generic Behavioural Change Campaign for COVID-19 Prevention

Evaluation Study

Zambia
Eli Lilly and Company

Completed

A Study of Evacetrapib (LY2484595) in Participants With Severe Renal Impairment and in Healthy Participants

Cardiovascular Disease

United States
Boehringer Ingelheim

Completed

Antiviral Effect, Safety, and Pharmacokinetics of BI201335 +PegIFN/RBV in HCV-GT1 (SILEN-C1&2)

Hepatitis C, Chronic

United States, Argentina, Australia, Austria, Canada, Czech Republic, France, Germany, Korea, Republic of, Netherlands, Portugal, Romania, Spain, Switzerland, United Kingdom
University of Nove de Julho

Unknown

Effect of Photobiomodulation Treatment in Individuals With Multiple Sclerosis:

Multiple Sclerosis

Brazil
Assiut University

Not yet recruiting

Analysis of Risk Factors of Diabetic Retinopathy

Diabetic Retinopathy
University of Leipzig

Unknown

Tissue Characterization With Hyperspectral Imaging (HSI) (HSIT)

Inflammation | Inflammatory Bowel Diseases | Tumor | Tissue Perfusion

Germany
Foundation for Liver Research

Completed

Entecavir for Chronic Hepatitis B

Entecavir for Chronic Hepatitis B Patients

Netherlands
Eli Lilly and Company

Completed

A Study of Evacetrapib (LY2484595) in Participants With Hepatic (Liver) Impairment

Hepatic Insufficiency

United States
Biogen

Completed

A Proof of Concept Study to Evaluate the Effectiveness of Tysabri in Relapsing Remitting Multiple Sclerosis (RRMS) Patient Bladder Function (TRUST)

Relapsing-Remitting Multiple Sclerosis
Janssen Pharmaceutical K.K.

Completed

A Study to Assess the Effectiveness, Safety, and Pharmacokinetics of TMC435 in Combination With Peginterferon Alfa-2a and Ribavirin in Hepatitis-C Infected Patients (DRAGON)

Hepatitis C, Chronic

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of TMC435 in Participants With Genotype 1 Hepatitis C Virus (HCV) Infection

Hepatitis C, Chronic

Japan
Grigore T. Popa University of Medicine and Pharmacy
Aristotle University Of Thessaloniki

Recruiting

Maxillary Molar Distalization Supported by Mini-implants With the Advanced Molar Distalization Appliance (Amda®)

Angle Class II

Romania
NYU Langone Health
National Center for Complementary and Integrative Health (NCCIH); Ananda Scientific

Recruiting

Cannabidiol as a Treatment for Social Anxiety Disorder (R61)

Social Anxiety Disorder

United States
University Health Network, Toronto

Recruiting

Palliative Thoracic ImmunoRT

Lung Cancer | Lung Cancer, Nonsmall Cell

Canada
Pamukkale University

Completed

The Effects Of Cervical Mobilization (CM)

Stroke | Ischemic Stroke | Chronic Stroke

Turkey
Cairo University

Unknown

Prevalence of Kidney Injury in Patients With HCV Treated With Sofuspovir Containing DAA Therapy

Investigate the Renal Effect of DAAs on Egyption Patients After Completion of Treatment

Egypt
Novartis Pharmaceuticals

Completed

Study to Evaluate the Efficacy and Safety of Glycopyrronium or Indacaterol Maleate and Glycopyrronium Bromide Fixed-dose Combination Regarding Symptoms and Health Status in Patients With Moderate COPD Switching From Treatment With Any Standard COPD Regimen

COPD

Germany, Belgium, Poland, Romania, Italy, Spain, Estonia, Russian Federation, Austria, France, Slovakia, Czechia, Latvia, Lithuania, Greece, Hungary, United Kingdom, Portugal, Ireland, Norway, Slovenia, Denmark, Sweden
Trans Tasman Radiation Oncology Group
Peter MacCallum Cancer Centre, Australia

Completed

Accelerated Partial Breast Irradiation for Early Breast Cancer

Breast Cancer

Australia, New Zealand
CHU de Reims

Completed

Association Between Hidradenitis Suppurativa and Spondyloarthritis (VESPA)

Hidradenitis Suppurativa

France
B. Braun Ltd. Centre of Excellence Infection Control

Terminated

Prospective Cohort Study on Tolerability & Safety of Uro-Tainer® Polihexanide 0.02%

Complications; Catheter, Urinary (Indwelling Catheter) (Suprapubic)

Belgium, Germany, Switzerland
Hartford Hospital

Not yet recruiting

Cannabidiol Effects on Fear Extinction in Social Phobia

Social Anxiety Disorder

United States
Bristol-Myers Squibb

Completed

A Phase 3, Comparative Study of Asunaprevir and Daclatasvir Combination Therapy Versus Telaprevir Therapy in Japanese HCV Subjects

Hepatitis C Virus Infection

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of TMC435 in Genotype 1, Hepatitis C-infected Patients Who Relapsed After Previous Interferon (IFN)-Based Therapy

Hepatitis C, Chronic

Japan
Region Skane
Lund University

Recruiting

Blood Leukocyte Profiling in Eosinophilic Type 2 Asthma: Influence of Systemic IL-5 Targeting

Asthma

Sweden
CMC Ambroise Paré

Completed

Thymic Function in Patients With COVID-19 (COVITHYM)

Covid19

France
Erasme University Hospital

Completed

Effects of Acute Long-acting Bronchodilation on Oxygenation and Peripheral Ventilation in COPD

Pulmonary Disease, Chronic Obstructive

Belgium
Janssen R&D Ireland

Completed

An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients (QUEST-1)

Hepatitis C

United States, Australia, Ukraine, United Kingdom, Germany, Spain, Mexico, Canada, New Zealand, Russian Federation, Puerto Rico, Romania
Janssen Pharmaceutical K.K.

Completed

A Phase III Study of TMC435 in Treatment-naive, Genotype 1, Hepatitis C-infected Patients

Hepatitis C, Chronic

Japan
National Institute of Diabetes and Digestive and...

Withdrawn

Hepatitis B Immune Globulin (HBIg) to Restore Immune Control in People With Chronic Hepatitis B

Chronic Hepatitis B

United States
Amsterdam UMC, location VUmc
Merck Sharp & Dohme LLC; Novartis; Uppsala University Hospital

Terminated

Nilotinib Plus Pegylated Interferon-α2b in CML

Chronic Myeloid Leukemia

Netherlands, Denmark, Sweden, Finland, Norway

Search clinical trials for: PegIFN lambda

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations